Equinox Overview
- Year Founded
-
2014

- Status
-
Private
- Employees
-
36

- Latest Deal Type
-
2ndary - Private
- Investors
-
4
Equinox General Information
Description
Developer of glaucoma treatment technology designed to treat diseases of the optic nerve. The company's technology uses an adjustable, non-surgical, non-pharmacological system that utilizes the natural laws of physics to balance pressures in and around the eye, enabling doctors to understand glaucoma based on a deep exploration of the physics of eye pressure.
Contact Information
Website
www.equinoxus.comCorporate Office
- 2424 South East Bristol Street
- Suite 250
- Newport Beach, CA 92660
- United States
Corporate Office
- 2424 South East Bristol Street
- Suite 250
- Newport Beach, CA 92660
- United States
Equinox Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Secondary Transaction - Private | Completed | Generating Revenue | ||||
5. Later Stage VC | 05-Sep-2019 | Completed | Generating Revenue | |||
4. Early Stage VC (Series B) | 03-Mar-2018 | Completed | Generating Revenue | |||
3. Seed Round | 19-Dec-2017 | Completed | Generating Revenue | |||
2. Grant | 01-Mar-2015 | Completed | Generating Revenue | |||
1. Angel (individual) | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Equinox Patents
Equinox Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
CA-3115926-A1 | Apparatus and methods to treat headaches | Inactive | 10-Oct-2018 | ||
JP-2021532920-A | Devices and methods for regulating ocular blood flow | Active | 09-Aug-2018 | ||
JP-2021528185-A | Eye treatment devices and methods using independent pressure sources | Active | 28-Jun-2018 | ||
JP-6926161-B2 | Therapeutic treatment of the eye with gas | Active | 09-Mar-2016 | ||
JP-6581317-B2 | Therapeutic treatment of the eye with gas | Active | 09-Mar-2016 | A61H35/02 |
Equinox Signals
Equinox Investors (4)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
---|---|---|---|---|
Flying L Partners | Venture Capital | Minority | ||
Visionary Venture Fund | Venture Capital | Minority | ||
Bluestem Capital Company | PE/Buyout | Minority | ||
National Space Biology Research Institute | Corporation |
Equinox FAQs
-
When was Equinox founded?
Equinox was founded in 2014.
-
Where is Equinox headquartered?
Equinox is headquartered in Newport Beach, CA.
-
What is the size of Equinox?
Equinox has 36 total employees.
-
What industry is Equinox in?
Equinox’s primary industry is Other Pharmaceuticals and Biotechnology.
-
Is Equinox a private or public company?
Equinox is a Private company.
-
What is Equinox’s current revenue?
The current revenue for Equinox is
. -
How much funding has Equinox raised over time?
Equinox has raised $36M.
-
Who are Equinox’s investors?
Flying L Partners, Visionary Venture Fund, Bluestem Capital Company, and National Space Biology Research Institute have invested in Equinox.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »